Jonas Brinck

Jonas Brinck

Anknuten till Forskning | Docent
E-postadress: jonas.brinck@ki.se
Besöksadress: C2:94, Karolinska Universitetssjukhuset Huddinge, 14186 Stockholm
Postadress: H7 Medicin, Huddinge, H7 Endokrinologi och diabetes Parini, 171 77 Stockholm
Del av:

Om mig

  • Senior consultant Endocrinology/Diabetology, MD PhD
    I started medical school at Uppsala university 1993 and completed my studies
    in 2002. During this period, I was also a PhD student and defended my thesis
    in 2000 at the of Department of Medical Biochemistry and Microbiology,
    Uppsala university. I have worked clinically at Karolinska university
    hospital since 2004 at the Medical unit Endocrinology in parallel to my
    research at the Dept of Medicine Huddinge (MEDH7), KI. I have done a
    post-doctorial fellowship at Geneva university hospital 2011-2015 in prof.
    Richard W James group studying lipoprotein functionality in cellbased models.
    I am today a senior consultant in endocrinology and diabetology. I am a
    key-opinion-leader in the field of dyslipidaemia in Sweden and I am an
    author/contributor to regional clinical guidelines.

Forskningsbeskrivning

  • My research focuses on epidemiological and experimental aspects of hereditary
    dyslipidaemias. I am a team leader in the newly formed Cardiometabolic unit
    at MEDH7 department under Professor Paolo Parini. In my research team is
    KI-associated researcher Karin Littmann, PhD student Tigist Wodaje, research
    nurse Viveca Åberg and medical student Simon Sjuls. We also perform clinical
    trials in phase II-III in the field of dyslipidaemia and lipid lowering
    therapy.
    We study hereditary dyslipidaemias including Familial hypercholesterolemia,
    elevated Lipoprotein(a) and Familial Chylomicronemia Syndrome and their
    effects on atherosclerotic cardiovascular disease, metabolic disease, and
    diabetes. In our clinical and experimental studies, we study their effects on
    coronary blood flow capacity, endothel function and calcified aortic valve
    disease biomarkers. In our epidemiological research, we are working with
    regional and national cohorts to study their impact on various forms of
    cardiovascular disease, development of cardiometabolic and liver disease.

Artiklar

Alla övriga publikationer

Anställningar

  • Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2022-2025

Examina och utbildning

  • Docent, endokrinologi och diabetes, Karolinska Institutet, 2021

Nyheter från KI

Kalenderhändelser från KI